Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field.
- DOI
- 10.1016/j.jcyt.2026.102903
- Published
- 2026 Aug
- Container
- Cytotherapy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcyt.2026.102903,
title = {Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field.},
author = {Torres A and Marin-Corral J and Adalia-Bartolome R and Briones C and Ibarz-Villamayor M and Castro P and Mañez R and Trenado J and Rodríguez L and Codinach M and Fernández-Sojo J and Coll R and Querol S and Delgadillo J and Lafuente R and Vives J},
year = {2026},
journal = {Cytotherapy},
doi = {10.1016/j.jcyt.2026.102903},
url = {https://doi.org/10.1016/j.jcyt.2026.102903}
}RIS
TY - JOUR TI - Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field. AU - Torres A AU - Marin-Corral J AU - Adalia-Bartolome R AU - Briones C AU - Ibarz-Villamayor M AU - Castro P AU - Mañez R AU - Trenado J AU - Rodríguez L AU - Codinach M AU - Fernández-Sojo J AU - Coll R AU - Querol S AU - Delgadillo J AU - Lafuente R AU - Vives J PY - 2026 JO - Cytotherapy DO - 10.1016/j.jcyt.2026.102903 UR - https://doi.org/10.1016/j.jcyt.2026.102903 ER -
APA
A, T., J, M., R, A., C, B., M, I., P, C., R, M., J, T., L, R., M, C., J, F., R, C., S, Q., J, D., R, L., & J, V. (2026). Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field.. Cytotherapy. https://doi.org/10.1016/j.jcyt.2026.102903
Source records
- pubmed · retrieved 2026-09-26T04:25:06.298Z
- europe-pmc · retrieved 2026-09-26T04:25:06.305Z